OrthoPediatrics (NASDAQ:KIDS) Shares Gap Down Following Analyst Downgrade

OrthoPediatrics Corp. (NASDAQ:KIDS) shares gapped down before the market opened on Wednesday after Stifel Nicolaus lowered their price target on the stock from $40.00 to $32.00. The stock had previously closed at $22.89, but opened at $22.28. Stifel Nicolaus currently has a buy rating on the stock. OrthoPediatrics shares last traded at $23.69, with a volume of 12,976 shares traded.

Other analysts have also recently issued research reports about the stock. Needham & Company LLC reissued a “buy” rating and issued a $42.00 price objective on shares of OrthoPediatrics in a research note on Wednesday. Truist Financial lowered their price objective on OrthoPediatrics from $28.00 to $25.00 and set a “hold” rating for the company in a research report on Wednesday, December 18th.

Institutional Investors Weigh In On OrthoPediatrics

Large investors have recently added to or reduced their stakes in the business. Quarry LP acquired a new stake in shares of OrthoPediatrics during the 3rd quarter worth approximately $25,000. International Assets Investment Management LLC increased its stake in OrthoPediatrics by 2,610.8% in the third quarter. International Assets Investment Management LLC now owns 1,003 shares of the company’s stock valued at $27,000 after purchasing an additional 966 shares in the last quarter. R Squared Ltd acquired a new position in shares of OrthoPediatrics during the fourth quarter valued at about $48,000. KLP Kapitalforvaltning AS bought a new position in shares of OrthoPediatrics during the 4th quarter worth about $79,000. Finally, BNP Paribas Financial Markets grew its stake in shares of OrthoPediatrics by 125.1% in the 3rd quarter. BNP Paribas Financial Markets now owns 3,471 shares of the company’s stock valued at $94,000 after buying an additional 1,929 shares during the period. Institutional investors and hedge funds own 69.05% of the company’s stock.

OrthoPediatrics Price Performance

The business has a 50-day moving average of $24.39 and a 200 day moving average of $25.94. The firm has a market capitalization of $579.13 million, a P/E ratio of -19.32 and a beta of 1.14. The company has a current ratio of 7.17, a quick ratio of 3.68 and a debt-to-equity ratio of 0.19.

OrthoPediatrics (NASDAQ:KIDS) last announced its quarterly earnings results on Tuesday, March 4th. The company reported ($0.29) EPS for the quarter, beating analysts’ consensus estimates of ($0.33) by $0.04. OrthoPediatrics had a negative net margin of 15.00% and a negative return on equity of 5.78%. The business had revenue of $52.67 million during the quarter, compared to analyst estimates of $51.16 million. During the same quarter in the previous year, the business posted ($0.23) EPS. On average, sell-side analysts predict that OrthoPediatrics Corp. will post -0.93 earnings per share for the current fiscal year.

OrthoPediatrics Company Profile

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.